Journal of Jilin University(Medicine Edition) ›› 2020, Vol. 46 ›› Issue (6): 1182-1186.doi: 10.13481/j.1671-587x.20200612
• Research in basic medicine • Previous Articles Next Articles
Effect of cardamonin on proliferation of cervical cancer HeLa cells and its mechanism
Yinfeng CUI1,Mengyu CHAI2,Wanshan YANG2(
),Ying PAN3()
- 1.Department of Stomatology，Affliated Hospital，Yanbian University，Yanji 133000，China
2.Department of Pathology，School of Medical Sciences，Yanbian University，Yanji 133002，China
3.Department of Obstetrics and Gynecology，China-Japanese Union Hospital，Jilin University，Changchun 130033，China
-
Received:2020-05-06Online:2020-11-28Published:2022-08-24 -
Contact:Wanshan YANG,Ying PAN E-mail:yangwsh@ybu.edu.cn;panying424@163.com
CLC Number:
- R737.33
Cite this article
Yinfeng CUI,Mengyu CHAI,Wanshan YANG,Ying PAN. Effect of cardamonin on proliferation of cervical cancer HeLa cells and its mechanism[J].Journal of Jilin University(Medicine Edition), 2020, 46(6): 1182-1186.
share this article
Fig.1
Cell viabilities of cervical cancer HeLa cells in various groups"
Fig.1
Fig.3
Clone formation number of cervical cancer HeLa cells in various groups"
Fig.3
Fig.5
Expressions of Bcl-2 and Bax proteins in cervical cancer HeLa cells in various groups"
Fig.5
Fig.6
Expressions of p-PI3K and p-AKT proteins in cervical cancer HeLa cells in various groups"
Fig.6
| 1 | SMALL W J R， BACON M A， BAJAJ A， et al. Cervical cancer： a global health crisis［J］. Cancer， 2017， 123（13）： 2404-2412. |
| 2 | LIN A J， DEHDASHTI F， GRIGSBY P W. Molecular imaging for radiotherapy planning and response assessment for cervical cancer［J］. Semin Nucl Med， 2019， 49（6）： 493-500. |
| 3 | JAMES S， APARNA J S， PAUL A M， et al. Cardamonin inhibits colonic neoplasia through modulation of MicroRNA expression［J］. Sci Rep， 2017， 7（1）： 13945. |
| 4 | JIN J M， QIU S P， WANG P， et al. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming［J］. J Exp Clin Cancer Res， 2019， 38（1）： 377. |
| 5 | LI Y T， QIN Y， YANG C S， et al. Retraction Note： Cardamonin induces ROS-mediated G2/M phase arrest and apoptosis through inhibition of NF-κB pathway in nasopharyngeal carcinoma［J］. Cell Death Dis， 2019， 10（4）： 289. |
| 6 | JIA D Y， TAN Y， LIU H J， et al. Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo ［J］. Oncotarget， 2016， 7（1）： 771-785. |
| 7 | HOU G C， YUAN X， LI Y， et al. Cardamonin， a natural chalcone， reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway［J］. Invest New Drugs， 2020， 38（2）： 329-339. |
| 8 | GLOBAL BURDEN OF DISEASE CANCER COLLABORATION， FITZMAURICE C， ALLEN C， et al. Global， regional， and national cancer incidence， mortality， years of life lost， years lived with disability， and disability-adjusted life-years for 32 cancer groups， 1990 to 2015： a systematic analysis for the global burden of disease study［J］. JAMA Oncol， 2017， 3（4）： 524-548. |
| 9 | COHEN P A， JHINGRAN A， OAKNIN A， et al. Cervical cancer［J］. Lancet， 2019， 393（10167）： 169-182. |
| 10 | DE CASTRO C C， COSTA P S， LAKTIN G T， et al. Cardamonin， a schistosomicidal chalcone from Piperaduncum L. （Piperaceae） that inhibits Schistosoma mansoni ATP diphosphohydrolase［J］. Phytomedicine， 2015， 22（10）： 921-928. |
| 11 | GONÇALVES L M， VALENTE I M， RODRIGUES J A. An overview on cardamonin［J］. J Med Food， 2014， 17（6）： 633-640. |
| 12 | NIU P G， SHI D H， ZHANG S S， et al. Cardamonin enhances the anti-proliferative effect of cisplatin on ovarian cancer［J］. Oncol Lett， 2018， 15（3）： 3991-3997. |
| 13 | XUE Z G， NIU P G， SHI D H， et al. Cardamonin inhibits angiogenesis by mTOR downregulation in SKOV3 cells［J］. Planta Med， 2016， 82（1/2）： 70-75. |
| 14 | NIU P G， ZHANG Y X， SHI D H， et al. Cardamonin inhibits metastasis of lewis lung carcinoma cells by decreasing mTOR activity［J］. PLoS One， 2015， 10（5）： e0127778 |
| 15 | RADOGNA F， DICATO M， DIEDERICH M. Cancer-type-specific crosstalk between autophagy， necroptosis and apoptosis as a pharmacological target［J］. Biochem Pharmacol， 2015， 94（1）： 1-11. |
| 16 | WANG G Y， ZHANG T， SUN W， et al. Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma［J］. Free Radic Biol Med， 2017， 106： 24-37. |
| 17 | BURGESS D J. Apoptosis： Refined and lethal［J］. Nat Rev Cancer， 2013， 13（2）： 79. |
| 18 | LIAO N C， SHIH Y L， CHOU J S， et al. Cardamonin induces cell cycle arrest， apoptosis and alters apoptosis associated gene expression in WEHI-3 mouse leukemia cells［J］. Am J Chin Med， 2019， 47（3）： 635-656. |
| 19 | ZHOU B H， TAN P P， JIA L S， et al. PI3K/AKT signaling pathway involvement in fluoride-induced apoptosis in C2C12 cells［J］. Chemosphere， 2018， 199： 297-302. |
| 20 | LI D D， LUO Z， CHEN G H， et al. Identification of apoptosis-related genes Bcl2 and Bax from yellow catfish Pelteobagrus fulvidraco and their transcriptional responses to waterborne and dietborne zinc exposure［J］. Gene， 2017， 633： 1-8. |
| 21 | CAO H W， FENG Y G， CHEN L， et al. Lobaplatin inhibits prostate cancer proliferation and migration through regulation of BCL2 and BAX［J］. Dose Response， 2019， 17（2）： 1559325819850981. |
| 22 | FENG F B， QIU H Y. Effects of Artesunate on chondrocyte proliferation， apoptosis and autophagy through the PI3K/AKT/mTOR signaling pathway in rat models with rheumatoid arthritis［J］. Biomed Pharmacother， 2018， 102： 1209-1220. |
| 23 | 李 翔， 张 斌， 马 竟， 等. Akt抑制剂MK2206对舌鳞癌TCA-8113细胞增殖和凋亡的影响及其作用机制［J］. 吉林大学学报（医学版）， 2014， 40（3）： 616-620. |
| 24 | ZHOU X S， ZHOU R， LI Q W， et al. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway［J］. Anticancer Drugs， 2019， 30（3）： 241-250. |